Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to learn whether tumor and nodal downstaging after neoadjuvant chemo-immunotherapy is associated with better surgical outcomes in patients with clinical stage I...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai Chest Hospital
Collaborators
NCT07478900 · Breast Cancer (Locally Advanced or Metastatic), Tattoo Skin Markers, and more
NCT06289062 · Cervical Cancer, Neoadjuvant Chemoimmunotherapy, and more
NCT06288373 · Cervical Cancer, Locally Advanced Cervical Cancer, and more
NCT06056336 · Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, and more
NCT07127497 · Pathological Complete Response, Rectal Cancer, and more
Fujian Medical University Union Hospital
Fuzhou, Fujian
Guangdong Provincial People's Hospital
Guangzhou, Guangdong
Shenzhen People's Hospital
Shenzhen, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions